Paper33804148
Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M and 6 others. Cells, 2021. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer. Papers, record 33804148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33804148
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Annexin A1 | Major topic |
| Cell Proliferation | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Pancreatic Neoplasms | Major topic |
| Cell Line, Tumor | |
| Cell Movement | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Neoplasm Invasiveness | |
| Neovascularization, Pathologic | |
| Prognosis | |
| Tumor Microenvironment |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA160688 | NCI NIH HHS | United States | R01CA160688 | PubMed and NIH | NIH RePORTER |
| CCR17481211 | Susan G. Komen | United States | PubMed | PubMed | |
| P30 CA016056 | NCI NIH HHS | United States | P30CA016056 | PubMed and NIH | NIH RePORTER |
| R01 CA250412 | NCI NIH HHS | United States | R01CA250412 | PubMed and NIH | NIH RePORTER |
| R37 CA248018 | NCI NIH HHS | United States | R37CA248018 | PubMed and NIH | NIH RePORTER |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27840982 | Annexin A1 is involved in resistance to 5-FU in colon cancer cells. | Oncol Rep | 2017 | https://conductscience.org/library/papers/27840982 | PubMed |
| 2 | 25983101 | ANXA1 silencing increases the sensitivity of cancer cells to low-concentration arsenic trioxide treatment by inhibiting ERK MAPK activation. | Tumori | 2015 | https://conductscience.org/library/papers/25983101 | PubMed |
| 3 | 32933189 | Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32933189 | PubMed |
| 4 | 31124054 | Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/31124054 | PubMed |
| 5 | 33633972 | Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer. | Gland Surg | 2021 | https://conductscience.org/library/papers/33633972 | PubMed |
| 6 | 23323831 | GSVA: gene set variation analysis for microarray and RNA-seq data. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23323831 | PubMed |
| 7 | 22213240 | Annexin A1: novel roles in skeletal muscle biology. | J Cell Physiol | 2012 | https://conductscience.org/library/papers/22213240 | PubMed |
| 8 | 11917092 | Annexins: from structure to function. | Physiol Rev | 2002 | https://conductscience.org/library/papers/11917092 | PubMed |
| 9 | 22460905 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | https://conductscience.org/library/papers/22460905 | PubMed |
| 10 | 30834048 | Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. | World J Oncol | 2019 | https://conductscience.org/library/papers/30834048 | PubMed |
| 11 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
| 12 | 24464914 | CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features. | Mol Cancer Res | 2014 | https://conductscience.org/library/papers/24464914 | PubMed |
| 13 | 25038797 | Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25038797 | PubMed |
| 14 | 32992708 | ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32992708 | PubMed |
| 15 | 32226772 | DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1. | Front Oncol | 2020 | https://conductscience.org/library/papers/32226772 | PubMed |
| 16 | 32485981 | Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32485981 | PubMed |
| 17 | 33477315 | Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC). | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33477315 | PubMed |
| 18 | 33024179 | M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. | Sci Rep | 2020 | https://conductscience.org/library/papers/33024179 | PubMed |
| 19 | 20308542 | Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20308542 | PubMed |
| 20 | 31926587 | Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. | Discov Med | 2019 | https://conductscience.org/library/papers/31926587 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42878980 | SERPINB5 promotes pancreatic adenocarcinoma progression through FBXO32-mediated regulation of epithelial-mesenchymal transition. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42878980 | PubMed |
| 42572768 | Cancer-Associated Fibroblasts in Gastrointestinal Cancer Metastasis: Mechanisms and Emerging Therapeutic Strategies. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42572768 | PubMed |
| 42277016 | Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42277016 | PubMed |
| 42065049 | A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer. | Oncol Res | 2026 | https://conductscience.org/library/papers/42065049 | PubMed |
| 41744829 | A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1. | Cells | 2026 | https://conductscience.org/library/papers/41744829 | PubMed |
| 41625126 | Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial-Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin-Induced Pulmonary Fibrogenesis. | Can Respir J | 2026 | https://conductscience.org/library/papers/41625126 | PubMed |
| 41593565 | The Gb3-synthase A4GALT is an epigenetically regulated driver of tumor invasiveness in gastrointestinal cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41593565 | PubMed |
| 41488282 | High CDCP1 Expression Reflects Immune and Stromal Remodeling and Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. | World J Oncol | 2026 | https://conductscience.org/library/papers/41488282 | PubMed |
| 41283264 | The Multifaceted Role of Annexin A1 in Colorectal Cancer: From Molecular Mechanisms to Predictive and Prognostic Implications. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/41283264 | PubMed |
| 41272387 | TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41272387 | PubMed |
| 41104873 | Epithelial‑mesenchymal plasticity and cisplatin resistance in germ cell tumors: Mechanisms and emerging therapeutic strategies (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/41104873 | PubMed |
| 40227604 | Annexin A1 Is Involved in the Antitumor Effects of 5-Azacytidine in Human Oral Squamous Carcinoma Cells. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40227604 | PubMed |
| 40125663 | Eosinophils-Induced Lumican Secretion by Synovial Fibroblasts Alleviates Cartilage Degradation via the TGF-β Pathway Mediated by Anxa1 Binding. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40125663 | PubMed |
| 40124331 | Gravitational forces and matrix stiffness modulate the invasiveness of breast cancer cells in bioprinted spheroids. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40124331 | PubMed |
| 39917002 | Knocking-down annexin A3 suppresses inflammation, oxidative stress, apoptosis, and endoplasmic reticulum stress to attenuate sepsis-induced acute kidney injury in HK2 cells. | Cytojournal | 2024 | https://conductscience.org/library/papers/39917002 | PubMed |
| 39867829 | Genes and proteins expression profile of 2D vs 3D cancer models: a comparative analysis for better tumor insights. | Cytotechnology | 2025 | https://conductscience.org/library/papers/39867829 | PubMed |
| 38972017 | Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression. | Breast Cancer Res Treat | 2024 | https://conductscience.org/library/papers/38972017 | PubMed |
| 38516766 | An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review). | Int J Oncol | 2024 | https://conductscience.org/library/papers/38516766 | PubMed |
| 38285765 | Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers. | Asian Pac J Cancer Prev | 2024 | https://conductscience.org/library/papers/38285765 | PubMed |
| 37954869 | Expression profiles of glucocorticoid-inducible proteins in human papilloma virus-related oropharyngeal squamous cell carcinoma. | Front Oral Health | 2023 | https://conductscience.org/library/papers/37954869 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33804148
GET https://conductscience.org/api/papers/v1/33804148/references?page=2